Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan;76(1):12-13.
doi: 10.1111/all.14544.

Translation of experimental immunotherapy

Affiliations
Editorial

Translation of experimental immunotherapy

Wayne Robert Thomas. Allergy. 2021 Jan.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Korotchenko E, Schiesl V, Scheiblhofer S, et al. Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. Allergy. 2020. https://doi.org/10.1111/all.14481
    1. Kashiwagi S, Brauns T, Poznansky MC. Classification of laser vaccine adjuvants. J Vaccines Vaccin. 2016;7(1):307.
    1. Fleischer DM, Spergel JM, Kim EH, et al. Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy. Allergy Asthma Proc. 2020;41(4):278-284.
    1. Senti G, von Moos S, Tay F, Graf N, Johansen P, Kündig TM. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70(6):707-710.
    1. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med. 2006;355(14):1445-1455.

Publication types

Substances

LinkOut - more resources